查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372849

外泌體研究市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、適應症、按應用、地區和競爭細分

Exosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028 Segmented by Product, By Indication, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年外泌體研究市場價值為1.8907 億美元，預計到2028 年將以13.71% 的年複合成長率實現顯著成長。這種成長可歸因於研發資金的激增，以及日益流行的外泌體研究市場。癌症和對基於外泌體的手術的興趣日益濃厚。此外，用於藥物開發和發現的外泌體技術的不斷進步預計將在這一預測時間內產生利潤豐厚的成長。同樣，藥物治療需求的不斷成長以及製藥業研發活動的激增仍然是多年來推動市場擴張的關鍵因素。值得注意的是，GLOBOCAN 2020 報告強調，全球癌症人口為 1,929 萬，預計這一數字在未來二十年將在全球範圍內激增。癌症病例的不斷增加表明外泌體在癌症管理中發揮重要作用的潛力很大，進一步促進了預期的市場成長。

擴大研究經費作為外泌體市場擴張的催化劑

研究經費的大幅增加是全球外泌體研究市場顯著成長的關鍵驅動力。這種不斷增加的資金使研究人員能夠對外泌體進行更廣泛和更全面的研究，最終導致對其生物學和前瞻性臨床應用有更深刻的了解。研究經費的增加促進了外泌體分離、分析和表徵的新技術和方法的發展。這反過來又導致了外泌體研究市場中新產品、服務、診斷和治療應用的創建。隨著資金的增加，研究人員可以拓寬外泌體研究的視野，使他們能夠探索外泌體生物學的新方面，並研究它們在更廣泛的疾病和病症中的潛在作用。研究範圍的擴大極大地增強了我們對外泌體臨床應用的理解，從而推動了外泌體研究市場的成長。

市場概況
預測期 2024-2028
2022 年市場規模 18907萬美元
2028 年市場規模 40419萬美元
2023-2028 年年複合成長率 13.71%
成長最快的細分市場 癌症
最大的市場 北美洲

研究經費的增加將外泌體研究轉變為更具吸引力的投資領域，導致外泌體研究市場上出現了新的公司和產品。這種投資的激增刺激了創新並加速了基於外泌體的療法和診斷的開發。值得注意的是，幾家公司已擴大其產品組合以涵蓋基於外泌體的療法。例如，Codiak Biosciences 與 Jazz Pharmaceuticals 合作，開創了以外泌體為基礎的癌症治療療法。外泌體研究市場的關鍵焦點是開發改良的外泌體分離技術。該領域的最新進展包括利用微流體裝置進行高通量外泌體分離，以及發展從特定細胞類型分離外泌體的新技術。

外泌體分離與分析技術的進步

外泌體分離和分析相關技術的進步對全球外泌體研究市場產生了深遠的影響。這些突破簡化並增強了外泌體的研究過程，有助於更全面地了解其生物學和潛在的臨床應用。這些技術進步提高了準確性和效率，使研究人員能夠獲得高品質的外泌體樣本並以更快的速度和精度進行分析。研究和開發活動的加速因此推動了外泌體研究市場的成長。新技術的出現使得即使是微量的外泌體也能被檢測和分析，提高了基於外泌體的檢測的靈敏度，並最終獲得更準確的結果。這揭示了新的研究途徑，並催化了外泌體研究市場中新穎產品和服務的推出。

對外泌體臨床潛力的認知增強刺激了市場前景

人們對外泌體潛在臨床應用的日益認知對全球外泌體研究市場產生了顯著影響。隨著研究人員和醫療專業人員越來越熟悉外泌體的獨特屬性和功能，人們對其作為治療和診斷工具的潛力的興趣呈指數級成長。隨著人們對外泌體潛在臨床應用的認知不斷提高，對基於外泌體的治療和診斷開發的投資也隨之激增。這最終導致外泌體研究市場中新公司和新產品的形成，從而推動成長並促進創新。外泌體的潛在臨床應用涵蓋多種疾病和病症，包括癌症、神經系統疾病和心血管疾病。

人們對這種潛力的認知不斷提高，促使人們加強開發基於外泌體的療法，從而引發外泌體研究市場中創新產品和服務的創建。此外，外泌體已被證明有望作為診斷各種疾病和病症的生物標記。人們對這種潛力的認知不斷增強，隨後催化了新的基於外泌體的診斷測試的製定，從而推動了外泌體研究市場的成長。隨著基於外泌體的療法和診斷越來越接近臨床實施，監管機構越來越深入參與開發和核准流程。人們對外泌體潛在臨床應用的認知不斷增強，促使監管部門加強審查，從而增強了基於外泌體的產品和服務的安全性和有效性。

慢性病盛行率激增為外泌體研究市場注入活力

慢性病的盛行率不斷上升對全球外泌體研究市場產生了重大影響。值得注意的是，癌症、心血管疾病和神經系統疾病等慢性疾病帶來了巨大的公共衛生挑戰，影響著全球數百萬人。外泌體已成為解決這些和其他慢性病的潛在診斷和治療工具，從而促進了外泌體研究市場的成長。

慢性病的激增促使研究重點加強，為探索外泌體在疾病診斷、治療和監測中的潛在作用提供了一個平台。隨著研究人員深入研究外泌體作為生物標記和治療劑的潛力，該市場持續蓬勃發展。外泌體引入了一種新的治療方法，能夠將藥物和遺傳物質輸送到特定的細胞和組織。

為了應對日益流行的慢性病，​​對創新療法的需求不斷成長，推動了基於外泌體的療法和產品的開發。值得注意的是，人們正在研究外泌體作為多種慢性疾病診斷工具的潛力。透過分析體液中存在的外泌體，研究人員可以識別出顯示疾病存在的生物標記。這反過來又刺激了基於外泌體的新診斷工具的開發，最終有助於外泌體研究市場的擴張。隨著外泌體成為應對日益嚴重的慢性疾病帶來的挑戰的有前途的解決方案，外泌體研究市場響應了這一需求，實現了成長和相關性。

市場區隔

全球外泌體研究市場可以按產品、適應症、應用和地區進行細分。根據產品，市場可分為試劑盒和試劑、儀器和其他產品。根據適應症，市場可分為癌症、神經退化性疾病、心血管疾病、傳染病等。根據應用，市場可分為生物標記、疫苗開發、組織再生和其他應用。

市場參與者

Thermo Fisher Scientific.、System Biosciences.、Bio-Techne.、Lonza.、QIAGEN.、ExoDx.、Hitachi Chemical.、Aethlon Medical.、NanoSomiX.、Malvern Panalytical.、Sistemic Sc​​ienceland Limited 和NX PharmaGen 是一些領先的公司全球外泌體研究市場的參與者。

報告範圍：

在本報告中，除了產業趨勢外，全球外泌體研究市場也分為以下幾類：

外泌體研究市場，副產品：

  • 試劑盒和試劑
  • 儀器
  • 其他產品

外泌體研究市場，依適應症分類：

  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 傳染性疾病
  • 其他

外泌體研究市場，按應用：

  • 生物標記
  • 疫苗開發
  • 組織再生
  • 其他應用

外泌體研究市場，按地區：

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

競爭格局

  • 公司概況：全球外泌體研究市場中主要公司的詳細分析。

可用的客製化：

  • 根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品分類
    • 按指示
    • 按應用
    • 按地區

第 6 章：北美外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲外泌體研究市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（試劑盒及試劑、儀器、其他產品）
    • 依適應症（癌症、神經退化性疾病、心血管疾病、傳染病、其他）
    • 按應用（生物標記、疫苗開發、組織再生、其他應用）
    • 按國家/地區
  • MEA：國家分析
    • 南非外泌體研究
    • 沙烏地阿拉伯外泌體研究
    • 阿拉伯聯合大公國外泌體研究

第 11 章：市場動態

  • 促進要素
    • 實驗室自動化活動的需求不斷成長
    • 生物樣本庫擴大採用實驗室資訊學
    • 越來越多引入技術先進的軟體服務
  • 挑戰
    • 缺乏實驗室資訊學整合標準
    • 嚴格的規定

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球外泌體研究市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Thermo Fisher Scientific.
    • System Biosciences.
    • Bio-Techne.
    • Lonza.
    • QIAGEN.
    • ExoDx.
    • Hitachi Chemical.
    • Aethlon Medical.
    • NanoSomiX.
    • Malvern Panalytical.
    • Sistemic Scotland Limited.
    • NX PharmaGen

第 16 章：策略建議

簡介目錄
Product Code: 15566

The exosome research market was valued at USD189.07 million in 2022, and is poised for remarkable growth with a CAGR Of 13.71% by 2028.. This growth can be attributed to a surge in research and development funding, coupled with an escalating prevalence of cancer and a heightened interest in exosome-based procedures. Furthermore, ongoing advancements in exosome technology for drug development and discovery are anticipated to yield lucrative growth during this forecast timeframe. Similarly, the escalating demand for drug therapies and a surge in research and development activities within the pharmaceutical industry remain pivotal factors driving market expansion over the years. Notably, the GLOBOCAN 2020 report underscores that the global cancer population stands at 19.29 million, with expectations of this number to surge over the next two decades worldwide. This mounting occurrence of cancer cases suggests a high potential for exosomes to play a significant role in cancer management, further contributing to the anticipated market growth.

Amplification in Research Funding as a Catalyst for Exosome Market Expansion

The substantial increase in research funding stands as a key driver behind the remarkable growth in the global exosome research market. This escalated funding has empowered researchers to undertake more extensive and comprehensive studies on exosomes, ultimately leading to a more profound understanding of their biology and prospective clinical applications. The augmented research funding has facilitated the development of novel technologies and methodologies for the isolation, analysis, and characterization of exosomes. This, in turn, has resulted in the creation of new products, services, diagnostics, and therapeutic applications within the exosome research market. With heightened funding, researchers can broaden the horizons of exosome research, allowing them to explore novel aspects of exosome biology and investigate their potential roles across a wider spectrum of diseases and conditions. This expanded research scope has significantly bolstered our understanding of the clinical applications of exosomes, thereby driving growth within the exosome research market.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 189.07 Million
Market Size 2028USD 404.19 Million
CAGR 2023-202813.71%
Fastest Growing SegmentCancer
Largest MarketNorth America

The increased research funding has transformed exosome research into a more appealing investment area, leading to the establishment of fresh companies and products in the exosome research market. This surge in investment has stimulated innovation and expedited the development of exosome-based therapies and diagnostics. Notably, several companies have expanded their portfolios to encompass exosome-based therapies. For instance, Codiak Biosciences has collaborated with Jazz Pharmaceuticals to pioneer exosome-based therapies for cancer treatment. A pivotal focus within the exosome research market has been the development of improved exosome isolation technologies. Recent advancements in this arena encompass the utilization of microfluidic devices for high-throughput exosome isolation and the formulation of new techniques for isolating exosomes from specific cell types.

Progressive Advancements in Exosome Isolation and Analysis Technologies

Advancements in technologies related to exosome isolation and analysis have exerted a profound impact on the global exosome research market. These breakthroughs have streamlined and enhanced the process of studying exosomes, contributing to a more comprehensive grasp of their biology and potential clinical applications. These technological headways have yielded enhanced accuracy and efficiency, allowing researchers to acquire high-quality exosome samples and conduct analyses with greater speed and precision. This acceleration of research and development activities has consequently driven growth within the exosome research market. Novel technologies have emerged that enable the detection and analysis of even minute quantities of exosomes, elevating the sensitivity of exosome-based assays and ultimately leading to more accurate results. This has unveiled fresh avenues of research and catalyzed the introduction of novel products and services within the exosome research market.

These technological strides have propelled the development of innovative products and services within the exosome research market, encompassing kits for exosome isolation and analysis, exosome-based diagnostics, and exosome-based therapeutics. These offerings have fueled growth within the exosome research market, creating novel prospects for companies operating in this sphere. The augmented accuracy and sensitivity afforded by advancements in exosome isolation and analysis technologies have furnished a more profound understanding of exosome biology and its significance in various diseases and conditions. This enriched comprehension has spurred the evolution of novel diagnostic and therapeutic applications for exosomes, thereby further contributing to the expansion of the exosome research market.

Heightened Awareness of the Clinical Potential of Exosomes Spurs Market Prospects

The burgeoning recognition of exosomes' potential clinical applications has exerted a noteworthy influence on the global exosome research market. As researchers and medical professionals become increasingly acquainted with the unique attributes and functions of exosomes, the interest in their potential as therapeutic and diagnostic tools has grown exponentially. As awareness surrounding the potential clinical applications of exosomes has escalated, investment in the development of exosome-based therapeutics and diagnostics has concurrently surged. This has culminated in the formation of novel companies and products within the exosome research market, thus driving growth and fostering innovation. The potential clinical applications of exosomes span a diverse range of diseases and conditions, including cancer, neurological disorders, and cardiovascular ailments.

The surging awareness of this potential has prompted intensified efforts toward the development of exosome-based therapies, thereby triggering the creation of innovative products and services within the exosome research market. Furthermore, exosomes have demonstrated promise as biomarkers for diagnosing various diseases and conditions. The increasing awareness of this potential has subsequently catalyzed the formulation of new exosome-based diagnostic tests, subsequently propelling the growth of the exosome research market. As exosome-based therapies and diagnostics edge closer to clinical implementation, regulatory bodies have become more deeply involved in the development and approval processes. The growing awareness of exosomes' potential clinical applications has spurred increased regulatory scrutiny, thereby fortifying the safety and efficacy of exosome-based products and services.

Surge in Prevalence of Chronic Diseases Energizes Exosome Research Market

The mounting prevalence of chronic diseases constitutes a significant influence on the global exosome research market. Notably, chronic ailments such as cancer, cardiovascular disease, and neurological disorders present substantial public health challenges, impacting millions globally. Exosomes have emerged as potential diagnostic and therapeutic tools for addressing these and other chronic conditions, consequently fueling growth within the exosome research market.

The upsurge in chronic diseases has prompted intensified research focus, offering a platform to explore the potential roles of exosomes in disease diagnosis, treatment, and monitoring. As researchers delve into the potential of exosomes as biomarkers and therapeutic agents, the market continues to flourish. Exosomes have introduced a new category of therapeutics, capable of delivering drugs and genetic material to specific cells and tissues.

The escalating demand for innovative treatments in response to the increasing prevalence of chronic diseases has propelled the development of exosome-based therapies and products. Remarkably, exosomes are being investigated for their potential as diagnostic tools for a diverse range of chronic ailments. Through the analysis of exosomes present in bodily fluids, researchers can identify biomarkers indicative of disease presence. This has, in turn, spurred the development of fresh exosome-based diagnostic tools, ultimately contributing to the expansion of the exosome research market. As exosomes emerge as a promising solution to the challenges posed by mounting chronic diseases, the exosome research market responds to this demand, attaining growth and relevance.

Market Segmentation

The global exosome research market can be segmented by product, indication, application, and region. Based on the product, the market can be segmented into kits and reagents, instruments, and other products. Based on indication, the market can be differentiated into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. Based on application, the market can be grouped into biomarkers, vaccine development, tissue regeneration, and other applications.

Market Players

Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, and NX PharmaGen are some of the leading players operating in the global exosome research market.

Report Scope:

In this report, the global exosome research market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Exosome Research Market, By Product:

  • Kits and Reagents
  • Instruments
  • Other Products

Exosome Research Market, By Indication:

  • Cancer
  • Neurodegenerative diseases
  • Cardiovascular diseases
  • Infectious diseases
  • Others

Exosome Research Market, By Application:

  • Biomarkers
  • Vaccine Development
  • Tissue Regeneration
  • Other Applications

Exosome Research Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Exosome Research Market.

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Exosome Research Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 5.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 5.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Products
    • 5.3.2 By Indication
    • 5.3.3 By Application
    • 5.3.4 By Region

6. North America Exosome Research Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 6.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 6.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Exosome Research Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Exosome Research Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Exosome Research Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Application

7. Europe Exosome Research Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 7.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 7.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Exosome Research Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Exosome Research Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Exosome Research Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Exosome Research Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Exosome Research Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Application

8. Asia-Pacific Exosome Research Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 8.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 8.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Exosome Research Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Application
    • 8.3.2. India Exosome Research Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Exosome Research Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Exosome Research Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Exosome Research Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Application

9. South America Exosome Research Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 9.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 9.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Exosome Research Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Exosome Research Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Exosome Research Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Application

10. Middle East and Africa Exosome Research Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Kits and Reagents, Instruments, Other Products)
    • 10.2.2. By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Others)
    • 10.2.3. By Application (Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Exosome Research Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Exosome Research Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Exosome Research Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing demand for lab automation activities
    • 11.1.2 Growing adoption of lab informatics by biobanks
    • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
    • 11.2.1 Lack of integration standards for laboratory informatics
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Exosome Research Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Thermo Fisher Scientific.
    • 15.6.2 System Biosciences.
    • 15.6.3 Bio-Techne.
    • 15.6.4 Lonza.
    • 15.6.5 QIAGEN.
    • 15.6.6 ExoDx.
    • 15.6.7 Hitachi Chemical.
    • 15.6.8 Aethlon Medical.
    • 15.6.9 NanoSomiX.
    • 15.6.10 Malvern Panalytical.
    • 15.6.11 Sistemic Scotland Limited.
    • 15.6.12 NX PharmaGen

16. Strategic Recommendations